Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock, including acquisitions of phantom units and holdings of employee stock options and restricted stock units.

Summary

  • On August 19, 2024, John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. [FUL], reported changes in his beneficial ownership of the company's securities.
  • The report details the acquisition of 96.63 phantom units on August 16, 2024, at a price of $81.17.
  • Corkrean directly owns 47,187 shares of common stock.
  • He also holds various employee stock options with different exercise prices and expiration dates, totaling 252,894 shares.
  • Additionally, he possesses restricted stock units that convert into common stock, totaling 7,812.99 shares.
  • The filing indicates that some options vest in installments, and restricted stock units also vest over time.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions and holdings.

Positives

  • The reporting person's continued holding of a significant amount of company stock and options could be interpreted as a positive sign of confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
  • The vesting schedules and exercise prices of the options are typical for executive compensation plans in publicly traded companies.
  • Companies like 3M, Avery Dennison, and Henkel also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

  • Shareholders may be interested in the insider transactions reported in this filing as an indicator of management's confidence in the company.

Key Dates

DateDescription
05/17/2017Date of employee stock option (Right-to-Buy) with an exercise price of $43.48 and an expiration date of 05/17/2026.
01/26/2018Date of employee stock option (Right-to-Buy) with an exercise price of $50.1 and an expiration date of 01/26/2027.
01/25/2019Date of employee stock option (Right-to-Buy) with an exercise price of $53.57 and an expiration date of 01/25/2028.
01/24/2020Date of employee stock option (Right-to-Buy) with an exercise price of $45.05 and an expiration date of 01/24/2029.
01/24/2021Date of employee stock option (Right-to-Buy) with an exercise price of $48.35 and an expiration date of 01/24/2030.
01/27/2022Date of employee stock option (Right-to-Buy) with an exercise price of $51.89 and an expiration date of 01/27/2031.
01/24/2023Date of employee stock option (Right-to-Buy) with an exercise price of $72.94 and an expiration date of 01/24/2032. Also, the vesting start date for restricted stock units.
01/24/2024Date of employee stock option (Right-to-Buy) with an exercise price of $68.17 and an expiration date of 01/24/2033. Also, the vesting start date for restricted stock units.
01/26/2025Date of employee stock option (Right-to-Buy) with an exercise price of $77.72 and an expiration date of 01/26/2034. Also, the vesting start date for restricted stock units.
08/16/2024Date of the transaction involving the acquisition of phantom units.
08/19/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.